0 items USD 0.00Search
Your search for "Deals" gave back 2714 results.
鈥淓merging Isotopes Pipeline Analysis and Global 麻豆原创 鈥� Forecast to 2029鈥� gives comprehensive insights on the various emerging isotope based...
颁补迟补濒辞驳:听
IQ4I
July 2022
Price: USD 4,950.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
颁补迟补濒辞驳:听
La Merie Publishing
January 2018
Price: USD 2,800.00
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals T-Cell Receptors (TCR) and Chimeric...
颁补迟补濒辞驳:听
La Merie Publishing
May 2018
Price: USD 2,500.00
鈥淒iabetic Foot Ulcer (DFU) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
颁补迟补濒辞驳:听
IQ4I
December 2018
Price: USD 3,600.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
颁补迟补濒辞驳:听
La Merie Publishing
February 2023
Price: USD 2,000.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
颁补迟补濒辞驳:听
La Merie Publishing
August 2023
Price: USD 2,365.00
Vectorized Antibodies for In Vivo Expression by DNA and mRNA report provides you with a landscape description and analysis of direct in vivo delivery...
颁补迟补濒辞驳:听
La Merie Publishing
July 2021
Price: USD 2,550.00
This report provides you with a landscape description and analysis of degrader-antibody conjugate (DAC) stakeholders, platform technologies,...
颁补迟补濒辞驳:听
La Merie Publishing
September 2024
Price: USD 2,300.00
Tubulin Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players Summary Tubulin Drugs in Development...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
May 2022
Price: USD 3,500.00
Dystrophin (DMD) - Drugs In Development, 2021 Summary According to the recently published report 'Dystrophin - Drugs In Development, 2021...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
June 2021
Price: USD 3,500.00
Pol Polyprotein - Drugs in Development, 2021 Summary Pol Polyprotein - Drugs in Development, 2021 provides in depth analysis on Pol Polyprotein...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
April 2021
Price: USD 3,000.00
Interferon Alpha (IFNA) - Drugs in Development, 2021 Summary Interferon Alpha (IFNA) - Drugs in Development, 2021 provides in depth analysis on...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
April 2021
Price: USD 3,000.00
Beta Tubulin (TUBB) - Drugs in Development, 2021 Summary Beta Tubulin (TUBB) - Drugs in Development, 2021 provides in depth analysis on Beta Tubulin...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
April 2021
Price: USD 3,000.00
Hemagglutinin 5 (H5) - Drugs in Development, 2021 Summary Hemagglutinin 5 (H5) - Drugs in Development, 2021 provides in depth analysis on...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
April 2021
Price: USD 3,000.00
听
